Back to search results

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Abroad (travel likely)
RecruitingPHASE2, PHASE3

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Metastatic Uveal Melanoma

Locations
  • HonorHealth Research Insisute, Scottsdale, Arizona, United States
  • UC San Diego Moores Cancer Center, La Jolla, California, United States
  • The Angeles Clinic and Research Institute, Los Angeles, California, United States
  • University of California Los Angeles, Los Angeles, California, United States
  • Stanford Cancer Institute, Palo Alto, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion(ACP), Aurora, Colorado, United States
  • The Melanoma & Skin Cancer Institute, Englewood, Colorado, United States
  • Georgetown University Medical Center, Washington D.C., District of Columbia, United States
  • Mayo Clinic - Jacksonville FL, Jacksonville, Florida, United States
  • Sylvester Comprehensive Cancer Center, Miami, Florida, United States
  • Emory Winship Cancer Institute, Atlanta, Georgia, United States
  • Northwestern Memorial Hospital, Chicago, Illinois, United States
  • University of Chicago Medical Center, Chicago, Illinois, United States
  • University of Iowa, Iowa City, Iowa, United States
  • Massachusetts General Hospital, Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Rochester, Minnesota, United States
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States
  • Duke University Medical Center, Durham, North Carolina, United States
  • The Ohio State University, Columbus, Ohio, United States
  • Thomas Jefferson University, Philadelphia, Pennsylvania, United States
  • UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
  • The West Clinic, PLLC dba West Cancer Center, Germantown, Tennessee, United States
  • University of Tennessee Medical Center, Knoxville, Tennessee, United States
  • Sarah Cannon Research Institute, Nashville, Tennessee, United States
  • Vanderbilt Ingram Cancer Center (Henry-Joyce Cancer Clinic), Nashville, Tennessee, United States
  • UT Southwestern Medical Center, Dallas, Texas, United States
  • The University Of Texas Md Anderson Cancer Center, Houston, Texas, United States
  • Fred Hutchinson Cancer Center, Seattle, Washington, United States
  • University Of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States
  • Melanoma Institute Australia, Wollstonecraft, New South Wales, Australia
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
  • The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, Merseyside, United Kingdom
  • The Royal Marsden NHS Foundation Trust, London, United Kingdom
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)